These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38391934)
1. Effects of the Phosphodiesterase 10A Inhibitor MR1916 on Alcohol Self-Administration and Striatal Gene Expression in Post-Chronic Intermittent Ethanol-Exposed Rats. Bertotto LB; Lampson-Stixrud D; Sinha A; Rohani NK; Myer I; Zorrilla EP Cells; 2024 Feb; 13(4):. PubMed ID: 38391934 [TBL] [Abstract][Full Text] [Related]
2. Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic-like effects without affecting cognitive enhancement and cataleptic effects in rats. Arakawa K; Maehara S Neuropsychopharmacol Rep; 2020 Jun; 40(2):190-195. PubMed ID: 32351052 [TBL] [Abstract][Full Text] [Related]
3. Intermittent Access to Ethanol Drinking Facilitates the Transition to Excessive Drinking After Chronic Intermittent Ethanol Vapor Exposure. Kimbrough A; Kim S; Cole M; Brennan M; George O Alcohol Clin Exp Res; 2017 Aug; 41(8):1502-1509. PubMed ID: 28679148 [TBL] [Abstract][Full Text] [Related]
4. Sex differences in the long-term effects of past stress on alcohol self-administration, glucocorticoid sensitivity and phosphodiesterase 10A expression. Logrip ML; Gainey SC Neuropharmacology; 2020 Mar; 164():107857. PubMed ID: 31756338 [TBL] [Abstract][Full Text] [Related]
5. A Selective Phosphodiesterase 10A Inhibitor Reduces L-Dopa-Induced Dyskinesias in Parkinsonian Monkeys. Beck G; Maehara S; Chang PL; Papa SM Mov Disord; 2018 May; 33(5):805-814. PubMed ID: 29508924 [TBL] [Abstract][Full Text] [Related]
6. Ameliorative effects of a phosphodiesterase 10A inhibitor, MR1916 on L-DOPA-induced dyskinesia in parkinsonian rats. Arakawa K; Yuge N; Maehara S Pharmacol Rep; 2020 Apr; 72(2):443-448. PubMed ID: 32144743 [TBL] [Abstract][Full Text] [Related]
8. Stress history increases alcohol intake in relapse: relation to phosphodiesterase 10A. Logrip ML; Zorrilla EP Addict Biol; 2012 Sep; 17(5):920-33. PubMed ID: 22741603 [TBL] [Abstract][Full Text] [Related]
9. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents. Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638 [TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase 10A selective inhibitor, TAK-063, induces c-Fos expression in both direct and indirect pathway medium spiny neurons and sub-regions of the medial prefrontal cortex in rats. Nakatani A; Nakamura S; Kimura H Neurosci Res; 2017 Dec; 125():29-36. PubMed ID: 28687229 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation. Threlfell S; Sammut S; Menniti FS; Schmidt CJ; West AR J Pharmacol Exp Ther; 2009 Mar; 328(3):785-95. PubMed ID: 19056933 [TBL] [Abstract][Full Text] [Related]
12. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [ de Laat B; Kling YE; Schroyen G; Ooms M; Hooker JM; Bormans G; Van Laere K; Ceccarini J Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):492-502. PubMed ID: 34142214 [TBL] [Abstract][Full Text] [Related]
13. Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A. Strick CA; James LC; Fox CB; Seeger TF; Menniti FS; Schmidt CJ Neuropharmacology; 2010 Feb; 58(2):444-51. PubMed ID: 19765598 [TBL] [Abstract][Full Text] [Related]
14. Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. Matzeu A; Terenius L; Martin-Fardon R Alcohol Clin Exp Res; 2018 Dec; 42(12):2466-2478. PubMed ID: 30320880 [TBL] [Abstract][Full Text] [Related]
15. Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease. Kleiman RJ; Kimmel LH; Bove SE; Lanz TA; Harms JF; Romegialli A; Miller KS; Willis A; des Etages S; Kuhn M; Schmidt CJ J Pharmacol Exp Ther; 2011 Jan; 336(1):64-76. PubMed ID: 20923867 [TBL] [Abstract][Full Text] [Related]
16. Balanced Activation of Striatal Output Pathways by Faster Off-Rate PDE10A Inhibitors Elicits Not Only Antipsychotic-Like Effects But Also Procognitive Effects in Rodents. Harada A; Kaushal N; Suzuki K; Nakatani A; Bobkov K; Vekich JA; Doyle JP; Kimura H Int J Neuropsychopharmacol; 2020 Feb; 23(2):96-107. PubMed ID: 31689714 [TBL] [Abstract][Full Text] [Related]
17. TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease. Harada A; Suzuki K; Kimura H J Pharmacol Exp Ther; 2017 Jan; 360(1):75-83. PubMed ID: 27811172 [TBL] [Abstract][Full Text] [Related]
18. Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats. Morales M; McGinnis MM; McCool BA Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):67-76. PubMed ID: 26515190 [TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486 [TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Ethanol Reward Seeking Under Conflict in Mice. Xie Q; Buck LA; Bryant KG; Barker JM Alcohol Clin Exp Res; 2019 Jul; 43(7):1556-1566. PubMed ID: 31034618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]